Patients Coming Off Anti-Obesity Jabs Regain Pounds Far More Rapidly Than People Using Diet and Exercise

New research suggests that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on lost weight much more quickly than those who halt traditional lifestyle plans.

Research printed in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using these drugs should be informed of the risk of rapid weight regain when the therapy concludes," warns lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to pre-treatment mass within about one and a half years.

Analyzing Therapies

The study, which reviewed dozens of trials involving thousands of participants, compared the effects of the injectable medications with older methods.

The team emphasize that people who shed pounds through dieting typically see a slower weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Experts propose the mode of action of the injections accounts for the heightened weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."

A Lifelong Issue?

The NHS suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.

A number of clinicians contend that, considering the likelihood of relapse, the therapy should be considered long-term.

This view is echoed by pharmaceutical companies, who say that the results "emphasize the persistent character of obesity," similar to managing diseases like high blood pressure.

User Testimonies

Users who have come off the jabs describe a intense resurgence of appetite.

"I experienced a switch flipping and you're instantly extremely hungry," described one woman.

This challenge is exacerbated if users have not developed lasting lifestyle or habit changes during treatment.

Growing Interest

Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is higher among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic solution and lasting health benefits relies on ongoing lifestyle management.